ADIAL PHARMACEUTICALS INC (ADIL)
US00688A2050 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ADIL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.34. This target is 908.14% above the current price.
ADIL was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ADIL.
In the previous month the buy percentage consensus was at a similar level.
ADIL was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-11 | Brookline Capital | Reiterate | Buy -> Buy |
| 2022-08-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-10-13 | Brookline Capital | Initiate | Buy |
| 2021-06-29 | Litchfield Hills | Initiate | Buy |